You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 4, 2024

METHAMPHETAMINE HYDROCHLORIDE - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic sources for methamphetamine hydrochloride and what is the scope of freedom to operate?

Methamphetamine hydrochloride is the generic ingredient in three branded drugs marketed by Ajenat Pharms, Teva, Able, Dr Reddys Labs Sa, Hikma, and Rexar, and is included in seven NDAs. Additional information is available in the individual branded drug profile pages.

There are four drug master file entries for methamphetamine hydrochloride. Two suppliers are listed for this compound.

Summary for METHAMPHETAMINE HYDROCHLORIDE
US Patents:0
Tradenames:3
Applicants:6
NDAs:7
Drug Master File Entries: 4
Finished Product Suppliers / Packagers: 2
Raw Ingredient (Bulk) Api Vendors: 31
Clinical Trials: 141
Patent Applications: 2,779
What excipients (inactive ingredients) are in METHAMPHETAMINE HYDROCHLORIDE?METHAMPHETAMINE HYDROCHLORIDE excipients list
DailyMed Link:METHAMPHETAMINE HYDROCHLORIDE at DailyMed
Recent Clinical Trials for METHAMPHETAMINE HYDROCHLORIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University of FloridaEarly Phase 1
Carolyn RodriguezPhase 2
Canadian Institutes of Health Research (CIHR)Phase 2

See all METHAMPHETAMINE HYDROCHLORIDE clinical trials

US Patents and Regulatory Information for METHAMPHETAMINE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Dr Reddys Labs Sa METHAMPHETAMINE HYDROCHLORIDE methamphetamine hydrochloride TABLET;ORAL 091189-001 Apr 21, 2010 AA RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Ajenat Pharms DESOXYN methamphetamine hydrochloride TABLET, EXTENDED RELEASE;ORAL 005378-004 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Teva METHAMPHETAMINE HYDROCHLORIDE methamphetamine hydrochloride TABLET;ORAL 086359-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Teva METHAMPEX methamphetamine hydrochloride TABLET;ORAL 083889-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Ajenat Pharms DESOXYN methamphetamine hydrochloride TABLET;ORAL 005378-002 Approved Prior to Jan 1, 1982 AA RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Rexar METHAMPHETAMINE HYDROCHLORIDE methamphetamine hydrochloride TABLET;ORAL 084931-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Ajenat Pharms DESOXYN methamphetamine hydrochloride TABLET, EXTENDED RELEASE;ORAL 005378-005 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.